Skip to main content
. 2020 Sep 25;11:4861. doi: 10.1038/s41467-020-18703-2

Fig. 7. Radiogenomic signatures validated as predictors of breast cancer prognosis.

Fig. 7

a, b Kaplan–Meier curves of survival in the prognostic assessment (p = 0.0013, two-sided log-rank test) and prognostic testing (p = 0.0015, two-sided log-rank test) datasets for overall survival and recurrence free survival, respectively. Red and blue plots represent poor survival and good survival groups, respectively.